January 20, 2022
Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and fulfillment solutions for the cell and gene therapy industry. Utilizing Nucleus Biologics’ proprietary platform, Cytiva customers will have [...]
Partnership with RoosterBio to advance scalable & continuous exosomes manufacture
January 20, 2022
Partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs. Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, [...]
Cytiva and Nucleus Biologics Join Forces
January 20, 2022
Cytiva welcomes Nucleus Biologics’ proven and powerful AI-powered interface that brings state-of-the-art cell media design and supply to the Cell and Gene Therapy Industry. Cell and gene therapies are critically reliant on the growth and maintenance of a viable and efficacious cell population. It is proven that cell culture media can have a profound impact [...]
ONI Closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital
January 20, 2022
Pioneers in observing single molecules in living cells Funds will be used to build a product portfolio that harnesses the company's innovative technology to unlock new possibilities in therapeutic and diagnostic development as well as basic life science research The company expands its management team and board of directors with the addition of several industry [...]
Genomenon Appoints New Chief Financial Officer to Leadership Team
January 20, 2022
Sean Kearney Joins Executive Team to Help Drive Continued Growth in Genomic Data Business ANN ARBOR, MICH. -- Following a year of 125% revenue growth, Genomenon®, Inc., an AI-driven genomics company, today announced that Sean Kearney has been appointed Chief Financial Officer (CFO), effective immediately. As a valuable member of Genomenon's executive leadership team, Mr. Kearney [...]
Akoya Biosciences Appoints Marilee Moy as Chief People Officer
January 20, 2022
Ms. Moy brings 30 years of HR leadership experience at high-performing companies MARLBOROUGH, Mass. -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People Officer. Ms. Moy has more than 30 years of HR leadership experience at high-performing life sciences and technology companies. She [...]
Release of the DT 9510 and ZT 730 with AirBasket
January 20, 2022
Langen ERWEKA GmbH is proud to start the year 2022 with two amazing new products – ERWEKAs first digital high-volume dissolution tester DT 9510 with its innovative AirLift system for easy raising and lowering of the dissolution head, and the new ZT 730 disintegration tester with AirBasket, ERWEKAs first cable-free disintegration basket with automatic determination [...]
January 20, 2022
Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms. RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, improving access for patients. FREDERICK, Md. -- Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today [...]
NANOLOGICA SIGNS CREDIT LINE WITH MAIN OWNER
January 19, 2022
Nanologica AB has signed a credit line of up to MSEK 50 with the company’s main owner Flerie Invest AB. The aim is to cover the company’s temporary financial needs pending expected cash flows from the preparative chromatography business, to meet the requirement of going concern for the next twelve months. This loan financing is [...]
Refeyn’s new SamuxMP mass photometer promises to significantly improve AAV workflows
January 19, 2022
New compact mass photometer enables rapid analysis of empty/full AAV capsid ratios at the bench Oxford, UK – Refeyn, the mass photometry pioneer, has announced the launch of its new SamuxMP mass photometer, which dramatically improves the time and cost efficiency of adeno-associated-virus (AAV) characterisation. Introduced at PepTalk, the SamuxMP overcomes the drawbacks of the current gold standard analytical methods [...]
